StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Specialty Care Portfolio Total [legacy pre-Q1 2026 by Year

Specialty Care Portfolio Total [legacy pre-Q1 2026 realignment, through Q4 2025] ($M) ($M)

QuarterlyAnnual

Pfizer Specialty Care Portfolio Total [legacy pre-Q1 2026: $17,546M in FY2025, up 5.4% from a year earlier.

Latest, FY2025
17,546
Period ended Dec 31, 2025
Change on a year earlier
+5.4%
16,652 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below

Where the FY2025 figure comes from

“|| Specialty Care | $ | 17,546 | $ | 16,652 | 5% | 5% | $ | 8,297 | $ | 7,981 | 4% | $ | 9,249 | $ | 8,671 | 7% | 6%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables & Form 10-K Segment Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Care Portfolio Total [legacy pre-Q1 2026 realignment, through Q4 2025] ($M) ($M)Year on yearSource
FY2025Dec 31, 202517,546+5.4%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2024Dec 31, 202416,652+11.1%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2023Dec 31, 202314,988+467.1%Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
FY2022Dec 31, 20222,643-8.4%Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2021Dec 31, 20212,886-79.8%Form 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗
FY2020Dec 31, 202014,280–Form 10-K (filed 2023-02-23) ↗

Breakdown

What makes up specialty Care Portfolio Total [legacy pre-Q1 2026

Cite this data

StockData. (2026). Pfizer Specialty Care Portfolio Total [legacy pre-Q1 2026 ($M), annual FY2020–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/port-leg-sc-ww

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.